Skip to Main Content
Insider Trading

Last Updated: 1 week ago

Conrad Wai has an estimated net worth of at least $10.9 million*, as of July 23, 2025. They own 3.1 million shares of CLOV stock. They have sold 209,797 shares of CLOV stock since 2021, for an estimated $49,561.

Conrad Wai $CLOV SEC Form 4 Insider Trading

Conrad Wai has filed a total of 2 insider trades in $CLOV since 2021. Their most recent trade was a sale of 118,600 shares, made on Jul 22, 2025. Their largest trade was a sale of 118,600 shares, made on Jul 22, 2025. We estimate that they now own 3.1 million shares of $CLOV, worth an estimated $10.8 million.



Insider Trading at $CLOV

There have been a total of 21 insider trades reported at $CLOV since 2021, with 3.5 million shares purchased and 579,548 shares sold. The most active insider traders in $CLOV stock have been Jamie L. Reynoso, Conrad Wai, and Brady Patrick Priest. The most recent trade was a sale of 118,600 shares reported by Conrad Wai (CEO, Counterpart Health), made on Jul 22, 2025.



History of Insider Stock Trades by Conrad Wai

Company Ticker Purchase / Sale Shares Date Disclosed (EST)
CLOV logo CLOV Sale 118,600 Jul 22, 2025 July 24, 2025, 4:11 p.m.
CLOV logo CLOV Sale 91,197 Jul 23, 2025 July 24, 2025, 4:11 p.m.




$CLOV Executives and Stock Owners with Insider Trades



*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.